Satellite Symposia

There are 9 interesting satellite symposia sponsored by our industrial partners, who chose the topics and speakers.

Wednesday, 22.11.2023

12:15 - 1:15 p.m.	AbbVie AG Tackling the status quo in lymphoma: Challenge to innovate in DLBCL- Optimize to benefit in CLL
12:15 - 1:15 p.m.	Eli Lilly Suisse SA Relapsed/Refractory MCL: Exploring New Options for Your Patients
12:15 - 1:15 p.m.	Gilead Sciences Switzerland Sàrl New therapeutic option in the treatment of patients with triple negative and HR+/Her2 metastatic breast cancer

Thursday, 23.11.2023

12:15 - 1:15 p.m.	AstraZeneca & Daiichi Sankyo Antibody-Drug-Conjugates: State of the Art and future developments
12:15 - 1:15 p.m.	BeiGene Switzerland BeiGene Innovation Forum: How technology and artificial intelligence could help to save time for the patient
12:15 - 1:15 p.m.	Janssen Cilag AG Prostate and Bladder Cancer Updates

Friday, 24.11.2023

12:15 - 1:15 p.m.	GSK Treatment paradigm shifts in endometrial cancer
12:15 - 1:15 p.m.	Pfizer AG Recent advances and future opportunities in the treatment of relapsed and refractory multiple myeloma
12:15 - 1:15 p.m.	Novartis Schweiz AG Unveiling the latest advances in PNH